Experiences with the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*: Deployability

Mapping the SFA ISR treatment landscape

Next steps: After the intervention in SFA ISR care

The conversation on collaterals in SFA ISR

Understanding sizing specifics: Covered stents in SFA ISR

AWR and Bilateral TAR Case Study with the GORE® ENFORM Biomaterial—John P. Fisher, M.D., MPH, FACS

Is Buttress Still a Staple of Bariatric Surgery? Randal Baker, M.D., FACS

Darren Schneider: 25 Years of TEVAR

Dr. Jordan Interview

TAMBE Product Animation

Introduction to TEVAR

Long-term vs. full cohort of VBX FLEX Study

Balloon expandable stents for AIOD

How outcomes inform treatment decisions

5-year VBX Stent Graft follow-up: Background

5-year VBX Stent Graft follow-up: Key outcomes

Rawad Mounzer, M.D., Teodor Pitea, M.D. and Amar Thosani, M.D. speak on Choosing the Right Stent

Jennie's Patient Story

National Principal Investigators share their perspectives on impact to LSA preservation procedures

Gore RELINE MAX Clinical Study Outcomes

The role of the VIABAHN® Device in SFA ISR treatment

Gore RELINE MAX Clinical Study Design and Objective

Experiences with the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*: Deployability

Covered stents and their contribution to patient outcomes

Challenges with PTA and the impact of repeat interventions